Nemaura Medical Inc. (NMRD)
undefined
undefined%
At close: undefined
0.12
59900.00%
After-hours Jan 04, 2024, 05:57 PM EST

Nemaura Medical Statistics

Share Statistics

Nemaura Medical has 40.35M shares outstanding. The number of shares has increased by 39.63% in one year.

Shares Outstanding 40.35M
Shares Change (YoY) n/a
Shares Change (QoQ) 39.63%
Owned by Institutions (%) n/a
Shares Floating 10.63M
Failed to Deliver (FTD) Shares 73
FTD / Avg. Volume 1.23%

Short Selling Information

The latest short interest is 52.57K, so 0.13% of the outstanding shares have been sold short.

Short Interest 52.57K
Short % of Shares Out 0.13%
Short % of Float 0.49%
Short Ratio (days to cover) 0.3

Valuation Ratios

The PE ratio is -1.57 and the forward PE ratio is null.

PE Ratio -1.57
Forward PE null
PS Ratio 289
Forward PS 0
PB Ratio -1.88
P/FCF Ratio -2.48
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Nemaura Medical Inc. has an Enterprise Value (EV) of 32.19M.

EV / Earnings -2.28
EV / Sales 417.83
EV / EBITDA -4.42
EV / EBIT -3.35
EV / FCF -3.58

Financial Position

The company has a current ratio of 0.61, with a Debt / Equity ratio of -1.7.

Current Ratio 0.61
Quick Ratio 0.53
Debt / Equity -1.7
Total Debt / Capitalization 243.8
Cash Flow / Debt -0.42
Interest Coverage -1.5

Financial Efficiency

Return on equity (ROE) is 1.2% and return on capital (ROIC) is -116.79%.

Return on Equity (ROE) 1.2%
Return on Assets (ROA) -0.97%
Return on Capital (ROIC) -116.79%
Revenue Per Employee 2.14K
Profits Per Employee -392.88K
Employee Count 36
Asset Turnover 0.01
Inventory Turnover 0.89

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.08, so Nemaura Medical 's price volatility has been higher than the market average.

Beta 0.08
52-Week Price Change null%
50-Day Moving Average 0
200-Day Moving Average 0.04
Relative Strength Index (RSI) 31.1
Average Volume (20 Days) 5.93K

Income Statement

In the last 12 months, Nemaura Medical had revenue of $77.04K and earned -$14.14M in profits. Earnings per share was $-0.57.

Revenue 77.04K
Gross Profit -1.48M
Operating Income -9.60M
Net Income -14.14M
EBITDA -7.29M
EBIT -9.60M
Earnings Per Share (EPS) -0.57
Full Income Statement

Balance Sheet

The company has $10.11M in cash and $20.03M in debt, giving a net cash position of -$9.93M.

Cash & Cash Equivalents 10.11M
Total Debt 20.03M
Net Cash -9.93M
Retained Earnings -51.88M
Total Assets 5.17M
Working Capital -18.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.45M and capital expenditures -$539.22K, giving a free cash flow of -$8.99M.

Operating Cash Flow -8.45M
Capital Expenditures -539.22K
Free Cash Flow -8.99M
FCF Per Share -0.36
Full Cash Flow Statement

Margins

Gross margin is -1.92K%, with operating and profit margins of -12.45K% and -18.36K%.

Gross Margin -1.92K%
Operating Margin -12.45K%
Pretax Margin -18.36K%
Profit Margin -18.36K%
EBITDA Margin -9.46K%
EBIT Margin -12.45K%
FCF Margin -11.67K%

Dividends & Yields

NMRD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield -111412.61%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NMRD.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Dec 5, 2019. It was a backward split with a ratio of 1:10.

Last Split Date Dec 5, 2019
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -25.18
Piotroski F-Score 1